Advanced search
Publication Cover
Biomarkers Volume 25, 2020 - Issue 3
Submit an article Journal homepage
1,232
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

High-frequency metabolite profiling and the incidence of recurrent cardiac events in patients with post-acute coronary syndrome

Maxime M. VroegindeweyDepartment of Cardiology, Erasmus University Medical Centre (Erasmus MC), Rotterdam, the Netherlands; ORCID Iconhttp://orcid.org/0000-0003-1607-5616View further author information
ORCID Icon,
Victor J. van den BergDepartment of Cardiology, Erasmus University Medical Centre (Erasmus MC), Rotterdam, the Netherlands; View further author information
,
Rohit M. OemrawsinghDepartment of Cardiology, Erasmus University Medical Centre (Erasmus MC), Rotterdam, the Netherlands; View further author information
,
Isabella KardysDepartment of Cardiology, Erasmus University Medical Centre (Erasmus MC), Rotterdam, the Netherlands; View further author information
,
Folkert W. AsselbergsDivision Heart and Lungs, Department of Cardiology, University Medical Centre Utrecht, University of Utrecht, Utrecht, the Netherlands; View further author information
,
Pim van der HarstDepartment of Cardiology, University Medical Centre Groningen, Groningen, the Netherlands; View further author information
,
Bas KietselaerDepartment of Cardiology, Maastricht University Medical Centre, Maastricht, the Netherlands; View further author information
,
Timo LenderinkDepartment of Cardiology, Zuyderland Hospital, Heerlen, the NetherlandsView further author information
,
K. Martijn AkkerhuisDepartment of Cardiology, Erasmus University Medical Centre (Erasmus MC), Rotterdam, the Netherlands; ORCID Iconhttp://orcid.org/0000-0003-4833-3130View further author information
ORCID Icon &
Eric BoersmaDepartment of Cardiology, Erasmus University Medical Centre (Erasmus MC), Rotterdam, the Netherlands; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-2559-7128View further author information
ORCID Icon show all
Pages 235-240 | Received 25 Apr 2019, Accepted 09 Feb 2020, Published online: 27 Feb 2020

References

  • Adiels, M., et al., 2005. Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia. Arteriosclerosis, thrombosis, and vascular biology, 25 (8), 1697–1703.
  • Boersma, E., et al., 2019. Details on high frequency blood collection, data analysis, available material and patient characteristics in BIOMArCS. Data in brief, 27, 104750.
  • Davidson, M.H., et al., 2011. Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists. Journal of clinical lipidology, 5 (5), 338–367.
  • Li, J., and Ji, L., 2005. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity, 95 (3), 221–227.
  • Liu, J., et al., 2006. Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease. The American journal of cardiology, 98 (10), 1363–1368.
  • O’donnell, C.J., and Nabel, E.G., 2011. Genomics of cardiovascular disease. New England journal of medicine, 365, 2098–2109.
  • Oemrawsingh, R.M., et al., 2016. Cohort profile of BIOMArCS: the BIOMarker study to identify the Acute risk of a Coronary Syndrome-a prospective multicentre biomarker study conducted in the Netherlands. BMJ open, 6 (12), e012929.
  • Rankin, N.J., et al., 2014. The emergence of proton nuclear magnetic resonance metabolomics in the cardiovascular arena as viewed from a clinical perspective. Atherosclerosis, 237 (1), 287–300.
  • Ren, J., et al., 2010. Long-term coronary heart disease risk associated with very-low-density lipoprotein cholesterol in Chinese: the results of a 15-Year Chinese Multi-Provincial Cohort Study (CMCS). Atherosclerosis, 211 (1), 327–332.
  • Rizopoulos, D., 2016. The R Package JMbayes for fitting joint models for longitudinal and time-to-event data using MCMC. 2016, 72, 46.
  • Rosenson, R.S., and Underberg, J.A., 2013. Systematic review: evaluating the effect of lipid-lowering therapy on lipoprotein and lipid values. Cardiovascular drugs and therapy, 27 (5), 465–479.
  • Ruiz-Canela, M., et al., 2017. Comprehensive metabolomic profiling and incident cardiovascular disease: a systematic review. Journal of the American heart association, 6 (10).
  • Sacks, F.M., et al., 2000. VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial. Circulation, 102 (16), 1886–1892.
  • Shah, S.H., and Newgard, C.B., 2015. Integrated metabolomics and genomics: systems approaches to biomarkers and mechanisms of cardiovascular disease. Circulation: cardiovascular genetics, 8 (2), 410–419.
  • Soininen, P., et al., 2015. Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circulation: cardiovascular genetics, 8 (1), 192–206.
  • Wurtz, P., et al., 2016. Metabolomic profiling of statin use and genetic inhibition of HMG-CoA reductase. Journal of the American college of cardiology., 67, 1200–1210.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.